Connect with us

Health

Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds – Science Daily

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new…

Published

on

Article feature image
Advertisement

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Camberwell residents put on COVID-19 alert after ‘unexpected’ wastewater result – 7NEWS.com.au
New Zealand’s bowel-cancer screening program saves lives: minister – Xinhua | English.news.cn – Xinhua